Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 69452-353

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 69452-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

180slabel (Image001)

Label for Acamprosate Calcium Delayed-Release Tablets 333 mg by Bionpharma Inc. The label indicates the product contains 180 tablets, each with 333 mg strength. It includes storage instructions, dosage advising to see package insert, and states the product is made in India. The label features the NDC 69452-353-25 and a barcode.*

FDA Label Image

Structure.jpg (Structure001)

Chemical structure diagram of acamprosate calcium, showing its molecular components with two equivalent parts each containing a carbamate group and a sulfonate group bound to a calcium ion (Ca2+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.